Westminster, CA - (NewMediaWire) - July 31, 2019 - BioLargo, Inc. (OTCQB:BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, today announced that its Canadian subsidiary BioLargo Water, Inc. ...

Westminster, CA - (NewMediaWire) - July 31, 2019 - BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, today announced that its engineering subsidiary has been awarded a third ...

SAN ANTONIO, TX - (NewMediaWire) - July 31, 2019 - Texas Oil & Minerals, Inc. recently merged with Golden Triangle Ventures, Inc. (“GTV”), a strategic consulting company doing business in the Health, Entertainment and Technology sectors, announced ...

WATCH "Midas Letter" CEO INTERVIEW on Low-Risk Film FinancingVancouver, BC - (NewMediaWire) - July 31, 2019 - The Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF), ("Wonderfilm" or the "Company"), a leading entertainment company with offices in ...

[Fort Lauderdale, FL - (NewMediaWire) - July 31, 2019 - Veritas Farms, Inc. (OTCQB: VFRM), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, is pleased to announce that its Veritas Farms\u2122 products have reached and surpassed over 4,500 points of retail distribution., , NewMediaWire, Veritas Farms\u2019 first and second quarter efforts in chain retail resulted in multiple national chain retailers launching Veritas Farms\u2122 products in their stores.\xa0 Total chain retail distribution added during this quarter represents thousands of additional stores across more than a dozen states., Alexander M. Salgado, CEO and co-founder of Veritas Farms, Inc., commented, \u201cWith our continued growth into independent retailer networks combined with the success of recent chain retail launches, we have reached distribution of our Veritas Farms\u2122 products into over 4,500 retail stores nationwide.\xa0 These established channels include prominent national chain retailers in pharmacy, grocery, and home-goods, as well as, independent retailers in grocery, pharmacy, chiropractic and medical professionals, spas, salons, hospitality, travel and specialty stores.\u201d, \u201cAs the Full Spectrum Hemp Oil category continues to build mainstream visibility and acceptance, the Veritas Farms team will maintain its efforts to create and capitalize on even more new and expanded retail opportunities.\xa0 We expect this will enable us to leverage our industry leading reputation for quality and consistency and will lead to a continued expansion of our retail distribution network going-forward.\u201d, Veritas Farms\u2122 brand full-spectrum hemp extract products can be found at several leading online and brick-and-mortar retailers across the United States.\xa0 For a complete listing of retailers and to purchase Veritas Farms\u2122 products online, visit\xa0www.theveritasfarms.com.\xa0, www.theveritasfarms.com, About Veritas Farms, Inc., About Veritas Farms, Inc., About Veritas Farms, Inc., Veritas Farms, Inc. (OTCQB: VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole plant, full spectrum hemp oils and extracts containing naturally occurring cannabinoids.\xa0 \xa0The Company currently owns and operates a 140-acre farm and production facility in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp.\xa0 The Company markets and sells products under its Veritas Farms\u2122 brand and manufactures private label products for a number of leading distributors and retailers.\xa0\xa0, Veritas Farms\u2122 brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in a variety of size formats and flavors.\xa0 All Veritas Farms\u2122 brand products are third-party laboratory tested for strength and purity.\xa0 The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at\xa0www.sec.gov., www.sec.gov, For additional information and online product purchase, visit\xa0www.theveritasfarms.com., www.theveritasfarms.com, Veritas Farms, Inc. - Investor ContactToll-Free: (888) 549-7888E-mail: ir@theveritasfarms.com, Veritas Farms, Inc. - Investor Contact, , , Veritas Farms, Inc. - Social MediaInstagram:\xa0\xa0www.instagram.com/veritasfarmsofficial/\xa0\xa0Facebook:\xa0www.facebook.com/VeritasFarmsOfficial/\xa0 \xa0LinkedIn:\xa0www.linkedin.com/company/veritasfarms/\xa0Twitter:\xa0www.twitter.com/theveritasfarms\xa0 \xa0, Veritas Farms, Inc. - Social Media, , www.instagram.com/veritasfarmsofficial/, , www.facebook.com/VeritasFarmsOfficial/, , www.linkedin.com/company/veritasfarms/, , www.twitter.com/theveritasfarms, Cautionary Language Concerning Forward-Looking Statements, Cautionary Language Concerning Forward-Looking Statements, This press release contains \u201cforward-looking statements\u201d within the meaning of the safe harbor ...

[Oregon Department of Forestry Purchases for Aerial Firefighting Program \xa0, Oregon Department of Forestry Purchases for Aerial Firefighting Program \xa0, , Jupiter, FL - (NewMediaWire) - July 31, 2019 - GelTech Solutions\u2019 Fire Services Division (OTCQB: GLTC),\xa0a leader in innovative, environmentally-friendly firefighting agents, is pleased to announce the first contract awarded for\xa0FireIce High Visibility Blue Medium-Term Retardant Gel\xa0(FireIce HVB-Fx). The Fire Services Division has partnered with the Oregon Department of Forestry (ODF) to supply the new firefighting agent. FireIce HVB-Fx can be utilized on both state and federal lands.\xa0 The first shipment of FireIce HVB-Fx is being delivered this week, and will be utilized on the Milepost 97 fire, which is currently impacting southwest Oregon., , NewMediaWire, OTCQB: GLTC, FireIce High Visibility Blue Medium-Term Retardant Gel\xa0, FireIce HVB-Fx, FireIce HVB-Fx is the first aerially applied firefighting agent to utilize a one-part, fugitive blue colorant package. The formula utilizes the latest technologies in colorants and performance additives, to maximize the effectiveness of the product while minimizing the environmental impact. The performance package improves the film thickness and wetting ability, providing better coverage, penetration, and greater overall effectiveness. FireIce HVB-Fx is also the first water enhancer to receive administrative approval from the United States Forest Service (USFS), under the newly revised, more challenging requirements of the Qualified Products List, specification 5100-306b. This listing qualifies FireIce HVB-Fx to be utilized on all federal lands, allowing federal agencies and cooperators to procure the product for use on wildland fires., About us:, Founded by Peter Cordani, our Chief Technology Officer, GelTech Solutions Inc\xa0(OTCQB: GLTC)\xa0is an innovator of environmentally friendly products that help support a sustainable future. GelTech\u2019s family of products are based on eco-friendly, non-toxic ingredients that enhance the properties of water. These products are currently used to help improve firefighting, protect assets, and help save lives. GelTech Solutions\u2019 Fire Services Division, based in Niwot, Colorado, specializes in providing cutting-edge FireIce suppression and retardant agents to wildland fire agencies and municipal fire departments around the world. Our team has extensive firefighting and aviation experience, allowing us to solve our customers greatest challenges.\xa0, For more information please visit\xa0geltechsolutions.com, follow us on Twitter\xa0@GelTechSol, or find us on LinkedIn at\xa0www.linkedin.com/company/geltechsolutions., geltechsolutions.com, @GelTechSol, www.linkedin.com/company/geltechsolutions, Media Contact:\xa0, Jessica Gilson\xa0Marketing Manager, GelTech Solutions Inc561.427.6144 | info@geltechsolutions.com, , , Investor Relations Contact:, Michael PorterPorter, LeVay & Rose212.564.4700 | mike@plrinvest.com\xa0, , ]

[New York, NY - (NewMediaWire) - July 31, 2019 - Tauriga Sciences, Inc. (OTCQB:\xa0TAUG) (\u201cTauriga\u201d or the \u201cCompany\u201d), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that will integrate Quick Response Codes (\u201cQR Codes\u201d) into its future product package design(s).\xa0 A QR code uses four standardized encoding modes (numeric, alphanumeric, byte/binary, and kanji) to store data efficiently; this will enhance a customer\u2019s ability to obtain pertinent product information (such as: laboratory generated Certificates of Analysis, ingredients, certifications, insurance information, and expiration dates).\xa0 The Company\u2019s Tauri-Gum\u2122 product line (CBD Infused Chewing Gum) was developed with both quality and consumer safety in mind.\xa0 Additionally, the Company plans to print mini cardboard Certificates of Analysis (\u201cC of A\u201d) to support its customer base.\xa0\xa0, , NewMediaWire, TAUG, In other news, the Company continues to experience strong levels of interest and demand from both existing customers as well as new ones.\xa0 The Company believes that its current operating quarter (2nd\xa0Fiscal Quarter of 2020) will demonstrate continued growth in its core business.\xa0\xa0, , nd, ABOUT TAURIGA SCIENCES INC., Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or \u201cCBD\u201d) infused chewing gum product business, as more fully described above and in prior press releases.\xa0 This CBD infused chewing gum product has been branded under the following name: Tauri-Gum\u2122.\xa0\xa0See also\xa0our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. \xa0Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at\xa0www.tauriga.com., ., In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-Gum\u2122 commercialization strategy.\xa0 This site can be accessed by visiting the following URL address:\xa0\xa0www.taurigum.com, The Company has established corporate offices in both New York City (USA) and Barcelona (Spain).\xa0, DISCLAIMER -- Forward-Looking Statements, , This press release contains certain \u201cforward-looking statements\u201d as defined by the Private Securities Litigation Reform Act of 1995 which represent management\u2019s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpects,\u201d \u201canticipates,\u201d believes, \u201chopes,\u201d \u201cbelieves,\u201d or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management\u2019s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, ...

[\nStudy Highlights: People were half as likely to have their blood pressure controlled in a six-year clinical trial if they received care in low-income areas.Study participants at low-income sites were more likely to die before the end of the research study or die from complications of heart failure.Physicians should consider socioeconomic and other factors in a patient\u2019s environment that may influence the effectiveness of traditional medical interventions and help reduce disparities and achieve more equitable outcomes. Embargoed until 4 a.m. CT / 5 a.m. ET Wednesday, July 31, 2019 (NewMediaWire) - July 31, 2019 - DALLAS - People enrolled in a large clinical hypertension management trial were half as likely to control their blood pressure if they received care at clinics and primary care practices in low-income areas, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association. Participants in a low-income area had a 25% higher chance of dying from any cause and a 25% higher likelihood of hospitalization and death related to heart failure over the course of the study period, than those receiving care in higher income areas. In addition, participants at low-income sites also had an 86% higher likelihood of developing end stage kidney disease and were 30% less likely to receive a procedure performed to open the blood vessels to the heart for patients experiencing chest pain or heart attack. The findings are based on data obtained from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), the largest randomized clinical trial of high blood pressure treatment in North America, which compared the effectiveness of three blood pressure lowering drugs. The study used 140/90 mm Hg as the threshold for high blood pressure, while the American Heart Association recognizes high blood pressure as 130/80 mm Hg. Researchers know that living in low-income areas is associated with higher rates of high blood pressure, heart failure and stroke. The new study explored whether cardiovascular outcomes vary by socioeconomic factors in a randomized clinical trial in which participants are treated equally.\xa0\xa0 \u201cTypically in a randomized controlled trial where we try to equalize care across treatment arms and across clinical sites, we aim to isolate the effect of a medication to understand its efficacy,\u201d said senior study author Erica Spatz, M.D., an associate professor of medicine at Yale School of Medicine. \u201cWhile medications are the mainstay of hypertension control, there are other factors that we need to pay attention to that are impacting blood pressure control, and the ultimate outcomes we care about - heart disease, stroke, hospitalization and longevity.\u201d ALLHAT enrolled men and women aged 55 years and older with untreated or treated hypertension in the United States, Canada, Puerto Rico and the Virgin Islands from 1994 to 2002. Because of differences in comparing socioeconomic status across geographic regions, the new study was restricted to the roughly 13,000 participants in the continental United States. Of these, 7.8% received care in the lowest income sites and 37.6% received care in the highest income sites. Participants in the low-income areas were more likely to be female, black, Hispanic, have fewer years of education and live in the South. Participants in low-income areas also surprisingly had fewer cardiovascular risk factors such as history of heart attack or stroke, Type 2 diabetes and cigarette smoking. Also, participants in the low-income areas visited their doctors less compared to higher income areas, potentially due to transportation access, social support and health behaviors which may have indirectly impacted some outcomes. The findings suggest that clinical trial design should consider the socioeconomic context of the treatment site and participants\u2019 neighborhoods. Co-authors are Andi Shahu, M.D., M.H.S.; Jeph Herrin, Ph.D.; Sanket S. Dhruva, M.D., ...

[\nStudy Highlights: Marijuana exposure damages cells of the inner lining of blood vessels throughout the heart and vascular system.In studies with human cells and arteries from mice, a compound found in soybeans blocked the damage and may have potential in preventing cardiovascular side effects of marijuana use. Embargoed until 3 p.m. CT / 4 p.m. ET, Tuesday, July 30, 2019 (NewMediaWire) - July 30, 2019 - BOSTON - In laboratory tests, a compound found in soybeans blocked damage to the lining of blood vessels in the heart and circulatory system and may someday provide a way to prevent the cardiovascular side effects of recreational and medical marijuana use, according to preliminary research presented at the American Heart Association\u2019s Basic Cardiovascular Sciences 2019 Scientific Sessions. Marijuana is the most widely used illicit drug worldwide and is increasingly being made legal for recreational and medicinal purposes. However, there have been studies that link marijuana smoking to an increased risk of heart attack and stroke. There can also be cardiovascular side effects, including changes in heart rate and blood pressure, when people take FDA-approved medications containing a synthetic version of delta-9-tetrahydrocannabinol (THC) \u2014 the main compound in marijuana that gives the sensation of being high. \u201cThese medications are prescribed to reduce the nausea and vomiting induced by chemotherapy and to increase appetite in certain people with acquired immune deficiency syndrome,\u201d said Tzu-Tan \u201cThomas\u201d Wei, Ph.D., the study\u2019s lead author and assistant professor of pharmacology in the College of Medicine at National Taiwan University in Taipei City. \u201cThe goal of our studies is to investigate the mechanisms of marijuana-induced damage and discover new drugs to prevent those side effects.\u201d The effects of THC occur after it binds to one of two cannabinoid receptors (CB1 and CB2) that are found throughout the brain and body and are also acted on by naturally occurring cannabinoids. In the current study, the researchers used endothelial cells (like those that line blood vessels) derived from the stem cells of five healthy people. Exposing the cells to THC, they found that: THC exposure induced inflammation and oxidative stress, which are known to affect the inner linings of blood vessels and are associated with the development of heart disease.Lab techniques that block access to the CB1 receptor by THC eliminated the effects of THC exposure on endothelial cells.Treatment with JW-1, an antioxidant compound found in soybeans, eliminated the effects of THC exposure. In addition, the researchers used a laboratory technique called wire myography to examine the response of mouse arteries to THC, finding that JW-1 blocked THC\u2019s negative effects on the function of the inner lining. An earlier attempt to gain health benefits from blocking the CB1 receptor proved problematic. \u201cPreviously, a drug that blocked CB1 was approved in Europe for the treatment of obesity, but it had to be withdrawn because of severe psychiatric side effects,\u201d Wei said. \u201cIn contrast, as an antioxidant, JW-1 may have neuroprotective effects. Discovering a new way to protect blood vessels without psychiatric side effects would be clinically important with the rapid growth of cannabis use worldwide.\u201d The researchers are currently extending their research by testing cells derived from regular marijuana users and those who smoke both cigarettes and marijuana. In addition, they are looking at the impact of THC along with the other main component of marijuana, cannabidiol. \u201cMeanwhile, if you have heart disease, talk to your doctor before you use marijuana or one of the synthetic THC-containing medications,\u201d Wei said. \u201cMarijuana may cause more severe effects on the cardiovascular system in those with pre-existing heart disease.\u201d Co-authors are Mark Chandy, M.D., Ph.D.; Ian Y. Chen, M.D., Ph.D.; Hung-Ta Wo, M.D.; Saereh Khanamiri, M.D., Ph.D.; Masataka Nishiga, M.D., Ph.D.; ...